Skip to main content
Fig. 4 | Journal of Hematology & Oncology

Fig. 4

From: Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia

Fig. 4

Cumulative incidence of 3-year a relapse, b TRM, c OS, d DFS, and e GRFS. The 3-year cumulative incidence of relapse were 18.9% ± 5.8% and 19.6% ± 5.7% in G-BM and G-PBSC groups (P = 0.840), and TRM were 8.2% ± 4.0% and 11.5% ± 4.5%, respectively, in G-BM and G-PBSC groups (P = 0. 549). The 3-year cumulative OS were 75.5% ± 6.7% and 69.6% ± 7.1%, respectively, in the G-BM and G-PBSC group (P = 0.426), and DFS were 72.9% ± 6.4% and 67.1% ± 6.6%, respectively, in the G-BM and G-PBSC groups (P = 0.456). The 1-year cumulative GRFS were 73.5% ± 6.3% vs 55.8% ± 6.9%, respectively, in the G-BM and G-PBSC groups (P = 0.049), and 2- and 3-year cumulative GRFS were 69.0% ± 6.7% vs 49.7% ± 7.0%, respectively, in the G-BM and G-PBSC groups (P = 0.03)

Back to article page